Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Decoding kinase-adverse event associations for small molecule kinase inhibitors.
Journal: Nature communications
Published: October 28, 2021
Regulatory Considerations for Contribution of Effect of Drugs Used in Combination Regimens: Renal Cell Cancer Case Studies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 02, 2020
Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 23, 2019
FDA Approval Summary: Nivolumab in Advanced Renal Cell Carcinoma After Anti-Angiogenic Therapy and Exploratory Predictive Biomarker Analysis.
Journal: The oncologist
Published: November 30, 2016
Showing 1-5 of 5
Last Updated: 09/26/2026